{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:51:21Z","timestamp":1790401881039,"version":"4.1.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:00:00Z","timestamp":1343952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Most commonly originating from breast malignancies, metastatic bone cancer causes bone destruction and severe pain. Although novel chemotherapeutic agents have increased life expectancy, patients are experiencing higher incidences of fracture, pain, and drug-induced side effects; furthermore, recent findings suggest that patients are severely undertreated for their cancer pain. Strong analgesics, namely opiates, are first-line therapy in alleviating cancer-related pain despite the severe side effects, including enhanced bone destruction with sustained administration. Bone resorption is primarily treated with bisphosphonates, which are associated with highly undesirable side effects, including nephrotoxicity and osteonecrosis of the jaw. In contrast, cannabinoid receptor 2 (CB2) receptor-specific agonists have been shown to reduce bone loss and stimulate bone formation in a model of osteoporosis. CB2 agonists produce analgesia in both inflammatory and neuropathic pain models. Notably, mixed CB1\/CB2 agonists also demonstrate a reduction in ErbB2-driven breast cancer progression. Here we demonstrate for the first time that CB2 agonists reduce breast cancer\u2013induced bone pain, bone loss, and breast cancer proliferation via cytokine\/chemokine suppression. Studies used the spontaneously-occurring murine mammary cell line (66.1) implanted into the femur intramedullary space; measurements of spontaneous pain, bone loss, and cancer proliferation were made. The systemic administration of a CB2 agonist, JWH015, for 7 days significantly attenuated bone remodeling, assuaged spontaneous pain, and decreased primary tumor burden. CB2-mediated effects in vivo were reversed by concurrent treatment with a CB2 antagonist\/inverse agonist but not with a CB1 antagonist\/inverse agonist. In vitro, JWH015 reduced cancer cell proliferation and inflammatory mediators that have been shown to promote pain, bone loss, and proliferation. Taken together, these results suggest CB2 agonists as a novel treatment for breast cancer\u2013induced bone pain, in which disease modifications include a reduction in bone loss, suppression of cancer growth, attenuation of severe bone pain, and increased survival without the major side effects of current therapeutic options. \u00a9 2013 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.1732","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T20:03:11Z","timestamp":1345233791000},"page":"92-107","source":"Crossref","is-referenced-by-count":68,"title":["Disease modification of breast cancer\u2013induced bone remodeling by cannabinoid 2 receptor agonists"],"prefix":"10.1093","volume":"28","author":[{"given":"Alysia N","family":"Lozano-Ondoua","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E","family":"Hanlon","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M","family":"Symons-Liguori","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tally M","family":"Largent-Milnes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh J","family":"Havelin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Henry L","family":"Ferland","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Chandramouli","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine, University of Arizona, Tucson, AZ, USA"},{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Owusu-Ankomah","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Nikolich-Zugich","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P","family":"Bloom","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Jimenez-Andrade","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"King","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, ME, USA"},{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, ME, USA"},{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W","family":"Mantyh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W","family":"Vanderah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, Biddeford, ME, USA"},{"name":"Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,3]]},"reference":[{"key":"2024020318444478000_bib1"},{"issue":"20 Pt 2","key":"2024020318444478000_bib2","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2024020318444478000_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10555-007-9100-0","article-title":"Immune cells as mediators of solid tumor metastasis","volume":"27","author":"DeNardo","year":"2008","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"2024020318444478000_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"2024020318444478000_bib5","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2011.39.2381","article-title":"Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer","volume":"30","author":"Fisch","year":"2012","journal-title":"J Clin Oncol"},{"issue":"35","key":"2024020318444478000_bib6","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"2024020318444478000_bib7","first-page":"775","article-title":"Wu DS","volume":"27","author":"Barkin","year":"2010","journal-title":"Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging"},{"issue":"5","key":"2024020318444478000_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00005131-199505000-00006","article-title":"Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats","volume":"9","author":"Altman","year":"1995","journal-title":"J Orthop Trauma"},{"key":"2024020318444478000_bib9","doi-asserted-by":"crossref","first-page":"a2041","DOI":"10.1136\/bmj.a2041","article-title":"Managing skeletal related events resulting from bone metastases","volume":"337","author":"Wilkinson","year":"2008","journal-title":"BMJ"},{"issue":"1\u20132","key":"2024020318444478000_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pain.2007.06.026","article-title":"Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer","volume":"132","author":"King","year":"2007","journal-title":"Pain"},{"issue":"18","key":"2024020318444478000_bib11","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance","volume":"20","author":"Vanderah","year":"2000","journal-title":"J Neurosci"},{"issue":"1","key":"2024020318444478000_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","article-title":"CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?","volume":"3","author":"Malan","year":"2003","journal-title":"Curr Opin Pharmacol"},{"issue":"18","key":"2024020318444478000_bib13","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2024020318444478000_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.228","article-title":"CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts","volume":"26","author":"Ofek","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024020318444478000_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2024020318444478000_bib16","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/hmg\/ddi370","article-title":"Cannabinoid receptor type 2 gene is associated with human osteoporosis","volume":"14","author":"Karsak","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2024020318444478000_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-9-196","article-title":"Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition","volume":"9","author":"Caffarel","year":"2010","journal-title":"Mol Cancer"},{"issue":"4","key":"2024020318444478000_bib18","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2024020318444478000_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1189\/jlb.0303101","article-title":"The cannabinoid system and immune modulation","volume":"74","author":"Klein","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"24","key":"2024020318444478000_bib20","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.2174\/138161206777947425","article-title":"Cannabinoids, immune system and cytokine network","volume":"12","author":"Massi","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"6","key":"2024020318444478000_bib21","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1084\/jem.193.6.F23","article-title":"Inflammatory cells and cancer: think different!","volume":"193","author":"Coussens","year":"2001","journal-title":"J Exp Med"},{"issue":"6","key":"2024020318444478000_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2024020318444478000_bib23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","article-title":"Impact of skeletal complications on patients' quality of life, mobility, and functional independence","volume":"16","author":"Costa","year":"2008","journal-title":"Support Care Cancer"},{"issue":"3","key":"2024020318444478000_bib24","first-page":"163","article-title":"Effect of bisphosphonates on pain and quality of life in patients with bone metastases","volume":"6","author":"Costa","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"issue":"9165","key":"2024020318444478000_bib25","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"2024020318444478000_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2354.2009.01135.x","article-title":"The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain","volume":"19","author":"Pockett","year":"2010","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"10","key":"2024020318444478000_bib27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/00007632-200405150-00006","article-title":"TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord","volume":"29","author":"Ohtori","year":"2004","journal-title":"Spine (PhilaPa 1976)"},{"issue":"9","key":"2024020318444478000_bib28","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2024020318444478000_bib29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"2024020318444478000_bib30","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","article-title":"Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain","volume":"19","author":"Schwei","year":"1999","journal-title":"J Neurosci"},{"key":"2024020318444478000_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1744-8069-7-81","article-title":"Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain","volume":"7","author":"Sukhtankar","year":"2011","journal-title":"Mol Pain"},{"issue":"17\u201318","key":"2024020318444478000_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.lfs.2010.02.014","article-title":"A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss","volume":"86","author":"Lozano-Ondoua","year":"2010","journal-title":"Life Sci"},{"issue":"1","key":"2024020318444478000_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"2024020318444478000_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"2024020318444478000_bib35","first-page":"4038","article-title":"Osteoprotegerin diminishes advanced bone cancer pain","volume":"61","author":"Luger","year":"2001","journal-title":"Cancer Res"},{"issue":"11","key":"2024020318444478000_bib36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1359\/jbmr.070711","article-title":"Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL\/6J mouse femur","volume":"22","author":"Koewler","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2024020318444478000_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-12-374895-9.00021-9","volume-title":"Bone cancer: progression and therapeutic approaches","author":"Tang","year":"2010"},{"issue":"(8 Suppl","key":"2024020318444478000_bib38","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"5","key":"2024020318444478000_bib39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"issue":"8","key":"2024020318444478000_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.299.8.937","article-title":"Spinal cord compression in patients with advanced metastatic cancer: \u201call I care about is walking and living my life","volume":"299","author":"Abrahm","year":"2008","journal-title":"JAMA"},{"issue":"17","key":"2024020318444478000_bib41","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM200310233491721","article-title":"Renal failure with the use of zoledronic acid","volume":"349","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"2024020318444478000_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/cncr.22504","article-title":"The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid","volume":"109","author":"Oh","year":"2007","journal-title":"Cancer"},{"key":"2024020318444478000_bib43","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jpainsymman.2005.01.008","article-title":"Bone cancer pain: from model to mechanism to therapy","volume":"29","author":"Luger","year":"2005","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2024020318444478000_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","article-title":"Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?","volume":"112","author":"Verri","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"7007","key":"2024020318444478000_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","article-title":"Cancer: an inflammatory link","volume":"431","author":"Balkwill","year":"2004","journal-title":"Nature"},{"issue":"6917","key":"2024020318444478000_bib46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"3","key":"2024020318444478000_bib47","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1476-5381.1992.tb14503.x","article-title":"The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia","volume":"107","author":"Cunha","year":"1992","journal-title":"Br J Pharmacol"},{"issue":"6","key":"2024020318444478000_bib48","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/sj.bjp.0703434","article-title":"Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist","volume":"130","author":"Cunha","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"12","key":"2024020318444478000_bib49","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ncb1507","article-title":"Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis","volume":"8","author":"Hiratsuka","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"6827","key":"2024020318444478000_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/35068566","article-title":"Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity","volume":"410","author":"Samad","year":"2001","journal-title":"Nature"},{"issue":"5","key":"2024020318444478000_bib51","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.0409225102","article-title":"A cascade of cytokines mediates mechanical inflammatory hypernociception in mice","volume":"102","author":"Cunha","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2024020318444478000_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bjp.0701148","article-title":"Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha","volume":"121","author":"Woolf","year":"1997","journal-title":"Br J Pharmacol"},{"issue":"3\u20134","key":"2024020318444478000_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/08923970701674997","article-title":"Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss","volume":"29","author":"Lunn","year":"2007","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"4","key":"2024020318444478000_bib54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/ALN.0b013e318167af74","article-title":"Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury","volume":"108","author":"Romero-Sandoval","year":"2008","journal-title":"Anesthesiology"},{"issue":"1","key":"2024020318444478000_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/neu.20080","article-title":"The endogenous cannabinoid system and its role in nociceptive behavior","volume":"61","author":"Cravatt","year":"2004","journal-title":"J Neurobiol"},{"issue":"7","key":"2024020318444478000_bib56","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bjp.0707320","article-title":"Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells","volume":"151","author":"Gkoumassi","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"39","key":"2024020318444478000_bib57","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.0503496102","article-title":"Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion","volume":"102","author":"White","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024020318444478000_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","article-title":"Chemokines and cytokines in neuroinflammation leading to neuropathic pain","volume":"12","author":"Kiguchi","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"13","key":"2024020318444478000_bib59","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2024020318444478000_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.1991.tb12502.x","article-title":"Interleukin-8 as a mediator of sympathetic pain","volume":"104","author":"Cunha","year":"1991","journal-title":"Br J Pharmacol"},{"issue":"12","key":"2024020318444478000_bib61","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1073\/pnas.0406030102","article-title":"A proinflammatory chemokine, CCL3, sensitizes the heat-and capsaicin-gated ion channel TRPV1","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024020318444478000_bib62","first-page":"34","article-title":"Facilitation and suppression of bone metastasis","volume":"(312)","author":"Mundy","year":"1995","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"2024020318444478000_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2024020318444478000_bib64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcp.21263","article-title":"Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells","volume":"214","author":"George","year":"2008","journal-title":"J Cell Physiol"},{"issue":"2","key":"2024020318444478000_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1067-1927.2005.130207.x","article-title":"Opioids heal ischemic wounds in the rat","volume":"13","author":"Poonawala","year":"2005","journal-title":"Wound Repair Regen"},{"issue":"Pt 3","key":"2024020318444478000_bib66","first-page":"471","article-title":"The permanent anatomical effects of neonatal capsaicin on somatosensory nerves","volume":"131","author":"Scadding","year":"1980","journal-title":"J Anat"},{"issue":"3","key":"2024020318444478000_bib67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0306-4522(91)90094-5","article-title":"Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats","volume":"44","author":"Hill","year":"1991","journal-title":"Neuroscience"},{"issue":"3","key":"2024020318444478000_bib68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10555-006-9003-5","article-title":"The multifaceted roles of chemokines in malignancy","volume":"25","author":"Ben-Baruch","year":"2006","journal-title":"Cancer Metastasis Rev"},{"issue":"16","key":"2024020318444478000_bib69","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"issue":"4","key":"2024020318444478000_bib70","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2006.02.016","article-title":"Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer","volume":"124","author":"Karin","year":"2006","journal-title":"Cell"},{"issue":"1","key":"2024020318444478000_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","article-title":"Autocrine IL-6 signaling: a key event in tumorigenesis?","volume":"13","author":"Grivennikov","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"2024020318444478000_bib72","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"2024020318444478000_bib73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejca.2006.01.012","article-title":"Tumour necrosis factor-alpha as a tumour promoter","volume":"42","author":"Szlosarek","year":"2006","journal-title":"Eur J Cancer"},{"key":"2024020318444478000_bib74","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1155\/2011\/565187","article-title":"Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy","volume":"2011","author":"Baay","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"2024020318444478000_bib75","first-page":"37","article-title":"Role of chemokines in the biology of natural killer cells","volume":"341","author":"Maghazachi","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"2024020318444478000_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellsig.2004.05.011","article-title":"Cannabinoids down-regulate PI3K\/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein","volume":"17","author":"Ellert-Miklaszewska","year":"2005","journal-title":"Cell Signal"},{"issue":"5","key":"2024020318444478000_bib77","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): Identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes Brain Behav"},{"issue":"9","key":"2024020318444478000_bib78","first-page":"697","article-title":"Economic\/societal burden of metastatic breast cancer: a US perspective","volume":"16","author":"Allen","year":"2010","journal-title":"Am J Manag Care"},{"issue":"1\u20132","key":"2024020318444478000_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant bone pain: pathophysiology and treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"2024020318444478000_bib80","author":"Harmon"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1732","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/1\/92\/56563222\/1732_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/1\/92\/56563222\/1732_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:47:40Z","timestamp":1710341260000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/28\/1\/92-107\/7598644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,3]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,8,3]]},"published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1732","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,1,1]]},"published":{"date-parts":[[2012,8,3]]}}}